6[6]Wang JS,Salahaddin A,Xia He,et al.Development of aflatoxin B1-lysine adduct monoclonal antibody for human exposure studies[J].App and Env Mic,2001,67(6):2712 -2717.
7[7]Wang JS,Huang TR,Su JJ,et al.Hepatocellular carcinoma and aflatoxin exposure in Zhuqing village,Fusui county,People's Republic of China,cancer epidemiology[J].Bio & Pre,2001,10(2):143-146.
9[9]Ayub M,Yatiml,Dileep S,et al.Carnitine alters binding of aflatoxin to DNA and proteins in rat hepatocytes and cell free systems[J].Journal of Nutrition,2001,131(7):1903 -1908.
10[10]Shen HM.Mutations of the P53 tumor suppressor gene and ras oncogenes in aflatoxin hepatocarcinogenesis[J].Mut Res,1996,366(1):23.
5ParkinDM, Bray F, Ferlay J. Global cancer statistics, 2002 [J]. CA Cancer J Clin,2005,55(2) :74-108.
6Wan JS, Salahaddin A. Xia He. et al. Develomem of aflatoxinBl-lysine adduct monoclonal antibody for human exposure studies[J]. Appand Env Mic,2001,67 (6) :2712-2717.
7Perera FP, Weinstein IB. Molecular epidemiology: recent ad vances and future direclions[J] . Carcino genesis, 2000, 21:517- 524.
8Poirier MC, Santella RM, Weston A. Carcinogen inacromo lecular adducts and their measurement[J]. Carcinogenesis 2000; 21(3):353-359.
9Wang JS, Huan TR, Su J J, et al. Hepatocelhll arcarcinoma and aflatoxin exposure in Zhuqing village, Fusui county , People's Republic of China, cancer epidemiology[J] Bio&- Pre,2001,10 (2) :143-146.
10Turner PC, SyllaA. Gong YY. Et al. Reduction in exposure to carcinogenic aflatoxins by postharvcst intervention measures in west Africa: acommunity--based intervene, ion study[J] Lancet, 2005, 365(9475) :1950-1956.
